Inventurus Knowledge Solutions (IKS) Q2 25/26 earnings summary

Executive summary

• Delivered strong Q2 FY26 results with 22% year-on-year revenue growth and 43% EBITDA growth, driven by AI adoption, operational transformation, and platform expansion.

• Expanded client base to over 450 enterprise customers, with 85%+ revenues from repeat clients and high retention.

• Recognized for innovation in AI-driven healthcare solutions, winning multiple industry awards and launching the industry's first encounter-to-reimbursement agentic AI platform.

• Board approved unaudited standalone and consolidated financial results for Q2 FY26, with statutory auditor review.

• The group operates as a single segment: a care enablement platform providing technology-enabled solutions to healthcare providers.

Financial highlights

• Q2 FY26 revenue reached INR 7,811 million, up 22% year-on-year and 5.5% quarter-on-quarter.

• EBITDA was INR 2,718 million (34.8% margin), up 43% year-on-year.

• PAT stood at INR 1,807 million, a 60% year-on-year increase and 23% margin.

• EPS for the quarter was INR 10.8, up 159% year-on-year.

• Operating cash flow for H1 FY26 was INR 3,984.8 million; free cash flow at INR 225 crores with a 124% FCF yield.

• Net debt reduced to INR 4,125 million as of September 30, 2025.

Outlook and guidance

• No formal guidance provided; management remains focused on outperforming the 12% TAM growth rate and sustaining mid-30s margin range.

• Continued investment in AI, technology platforms, and R&D to drive future growth and operational efficiency.

• Robust pipeline for large, outcome-oriented platform deals; interest at an all-time high.

• Expanded equity interest in IKS WWMG MSO LLC to 48.02% during the period.